Cargando…
Life Expectancy for Patients From the Southeastern United States With IgA Nephropathy
INTRODUCTION: Although end-stage renal disease (ESRD) and surrogate markers for renal dysfunction are frequently used as outcome markers for IgA nephropathy, the clinical course after reaching ESRD is not well documented. This study examined outcomes of progression to ESRD and age at death in a coho...
Autores principales: | Hastings, M. Colleen, Bursac, Zoran, Julian, Bruce A., Villa Baca, Emanuel, Featherston, Jennifer, Woodford, Susan Y., Bailey, Lisa, Wyatt, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762959/ https://www.ncbi.nlm.nih.gov/pubmed/29340319 http://dx.doi.org/10.1016/j.ekir.2017.08.008 |
Ejemplares similares
-
Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017) -
Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012) -
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012) -
Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016) -
Genetic studies of IgA nephropathy: past, present, and future
por: Kiryluk, Krzysztof, et al.
Publicado: (2010)